Clinical relevance of TNM staging system according to breast cancer subtypes. (Q53442213)

14 May 2018

title

Clinical relevance of TNM staging system according to breast cancer subtypes. (English)

1 reference

14 May 2018

author name string

Y H Park

1

1 reference

14 May 2018

S J Lee

2

1 reference

14 May 2018

E Y Cho

3

1 reference

14 May 2018

Y La Choi

4

1 reference

14 May 2018

J E Lee

5

1 reference

14 May 2018

S J Nam

6

1 reference

14 May 2018

J-H Yang

7

1 reference

14 May 2018

J H Shin

8

1 reference

14 May 2018

E Y Ko

9

1 reference

14 May 2018

B-K Han

10

1 reference

14 May 2018

J S Ahn

11

1 reference

14 May 2018

Y-H Im

12

1 reference

14 May 2018

publication date

17 January 2011

1 reference

14 May 2018

published in

Annals of Oncology

1 reference

14 May 2018

volume

22

1 reference

14 May 2018

issue

7

1 reference

14 May 2018

page(s)

1554-1560

1 reference

14 May 2018

Molecular portraits of human breast tumours

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Gene-Expression Profiles in Hereditary Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

BRCA1, a potential predictive biomarker in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Hallmarks of 'BRCAness' in sporadic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Triple-negative breast cancer: therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Triple-negative breast cancer: correlation between MR imaging and pathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics,BRCAmutations and oophorectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Review of the development of letrozole and its use in advanced breast cancer and in the neoadjuvant setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Pattern of metastatic spread in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

Mammographic, US, and MR imaging phenotypes of familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ617

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDQ617

1 reference

14 May 2018

1 reference

14 May 2018